Skip to main content
Stock Expert AI
Equity research screen

Biotech Stocks to Watch

24 US-listed stocks, ranked by a size, day-move and cash-flow composite. List built from FMP data as of 2026-10-09.

Quick Answer Biotech Stocks to Watch: 24 US-listed stocks ranked by a size, day-move and cash-flow composite, as of 2026-10-09. 11 of the 24 stocks listed have a MoonshotScore of 70 or higher; 3 have no published MoonshotScore. Each row shows the stored MoonshotScore, price and market cap and links to the stock page.
Stocks24Screens3List built2026-10-09Prices as ofOct 9, 2026 session

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.

MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.

21,000+ US companies analyzed

About the Biotech Stocks list

This list shows 24 stocks listed in the US, drawn from 49 US common-stock listings the FMP screen returned as of 2026-10-09. Each row links to the stock's own page.

Names rising to the top of the screen

The strongest names remain easy to scan without losing the valuation context behind the ranking.

Names rising to the top of the screen — ranked by a size, day-move and cash-flow composite (formula under "How the list is built"); MoonshotScore is not the sort key. List built 2026-10-09 (order and screen criteria as of that day); prices, day change and market cap as of the Oct 9, 2026 trading session (FMP quote); MoonshotScore as of 2026-10-09, shown for reference (not the sort key).
# Ticker Company MoonshotScore Price Change Market Cap
1 VRTX Vertex Pharmaceuticals Incorporated 97 $510.08 +1.36% $129.5B
2 REGN Regeneron Pharmaceuticals, Inc. 94 $746.54 +0.94% $76.9B
3 MRNA Moderna, Inc. 31 $225.00 +14.21% $89.3B
4 INCY Incyte Corporation 98 $112.79 +0.04% $22.9B
5 RVMD Revolution Medicines, Inc. 55 $189.76 +0.87% $40.3B
6 ALNY Alnylam Pharmaceuticals, Inc. 90 $232.68 +3.63% $31.1B
7 UTHR United Therapeutics Corporation 97 $549.16 +3.07% $23.3B
8 EXEL Exelixis, Inc. 98 $59.86 +1.42% $15.0B
9 NBIX Neurocrine Biosciences, Inc. 93 $142.44 +0.84% $14.3B
10 HALO Halozyme Therapeutics, Inc. 97 $110.42 +0.53% $13.1B
11 BMRN BioMarin Pharmaceutical Inc. 65 $54.80 -0.17% $10.6B
12 TECH Bio-Techne Corporation 93 $72.46 +0.01% $11.3B
13 INSM Insmed Incorporated — $100.60 +0.12% $21.8B
14 CAI Caris Life Sciences, Inc. 89 $29.70 +8.00% $8.4B
15 TXG 10x Genomics, Inc. 39 $80.65 +4.36% $10.2B
16 PTGX Protagonist Therapeutics, Inc. 76 $143.73 +2.73% $9.2B
17 TGTX TG Therapeutics, Inc. 66 $55.37 +3.81% $8.5B
18 TWST Twist Bioscience Corporation 36 $159.78 +5.08% $9.9B
19 SMMT Summit Therapeutics Inc. 52 $17.59 +2.45% $14.0B
20 ARWR Arrowhead Pharmaceuticals, Inc. 30 $62.75 +3.31% $8.8B
21 AXSM Axsome Therapeutics, Inc. 33 $168.35 -1.02% $8.7B
22 MDGL Madrigal Pharmaceuticals, Inc. 33 $471.75 -1.08% $10.9B
23 BBIO BridgeBio Pharma, Inc. — $65.35 +0.48% $12.8B
24 IBRX ImmunityBio, Inc. — $10.51 +6.05% $11.0B

Where valuation pressure is clustering

Share of the 24 listed stocks by sector (snapshot 2026-10-09).

Healthcare100%

What the numbers show

  • VRTX (Vertex Pharmaceuticals Incorporated) ranks first on this list, ranked by a size, day-move and cash-flow composite.
  • 11 of the 24 stocks listed have a MoonshotScore of 70 or higher; 3 have no published MoonshotScore.
  • By MoonshotScore band: 10 Exceptional (80-100), 3 Strong (65-79), 2 Fair (45-64), 6 Weak (below 45).
  • INCY (Incyte Corporation) has the highest MoonshotScore on the list: 98 (Exceptional).
  • When the list was built (2026-10-09), the median market cap of the 24 stocks with a reported market cap was $12.9B; the largest was VRTX at $129.5B.
  • 13 of the 24 stocks have a positive trailing P/E; the median among them was 29.1.

Disclaimer

This is educational content, not investment advice. Past performance does not guarantee future results.
“MoonshotScore rates a US-listed stock 0 to 100 using five sector-relative pillars. Higher means stronger numbers across business quality, safety, valuation, growth and momentum. Eligible common stocks and ADRs only; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
— Stock Expert AI published methodology (how MoonshotScore works)

Questions worth resolving before acting on the screen

How many stocks are on the Biotech Stocks list?

24 US-listed stocks as of 2026-10-09, out of 49 US common-stock listings the FMP screen returned.

Which stock ranks first on the Biotech Stocks list?

VRTX (Vertex Pharmaceuticals Incorporated) ranks first, ranked by a size, day-move and cash-flow composite as of 2026-10-09. Its MoonshotScore is 97 (Exceptional), as of 2026-10-09.

How many stocks on this list have a MoonshotScore of 70 or higher?

11 of the 24 stocks listed have a MoonshotScore of 70 or higher; 3 have no published MoonshotScore. (MoonshotScore as of 2026-10-09.)

Which stock on this list had the largest market cap when the list was built?

VRTX (Vertex Pharmaceuticals Incorporated), at $129.5B as of 2026-10-09.

How is this list ordered?

It is ordered by a composite of market cap ÷ $10B (capped at 20) plus 2 × the positive day change plus 20 × FCF yield. The MoonshotScore is shown for reference and is not the sort key.

When was this list last built?

The list was built from FMP data as of 2026-10-09; MoonshotScore as of 2026-10-09. The table's price, day change and market-cap columns show the latest FMP quote when one is available, dated in the table caption.

Explore More Research

Stock Expert AI provides data and analysis tools for educational purposes. This is not financial advice. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.